Flameng W, Sergeant P, Vanhaecke J, Suy R
J Thorac Cardiovasc Surg. 1987 Jul;94(1):124-31.
Emergency aorta-coronary bypass grafting was performed early in the course of evolving myocardial infarction in 48 patients. The time interval between the onset of symptoms and reperfusion was 169 +/- 80 minutes. Quantitative assessment of postoperative thallium 201 myocardial scans in 19 patients revealed a significant salvage of myocardium after surgical reperfusion: The size of the residual infarction was less than 50% of that in a matched, medically treated, prospective control group (n = 39) (p less than 0.05). Postoperative equilibrium-gated radionuclide blood pool studies (technetium 99m) showed an enhanced recovery of regional and global ejection fraction after operation as compared to after medical treatment (p less than 0.05). Ultrastructural evaluation of biopsy specimens obtained during the operation delineated subendocardial necrosis in the majority of cases (72%), but subepicardial necrosis was found in only 6% of instances. Q-wave abnormalities were observed on the postoperative electrocardiogram in 50% of cases. Operative mortality was 0% in low-risk patients (i.e., hemodynamically stable condition, n = 26) and 18% in high-risk patients (i.e., cardiogenic shock including total electromechanical dysfunction, n = 22). Survival rate at 18 months was 92% +/- 4%, and 95% +/- 4% of the survivors were event free. It is concluded that early surgical reperfusion of evolving myocardial infarction limits infarct size significantly, enhances functional recovery, and may be a lifesaving operation in patients having cardiogenic shock associated with unsuccessful resuscitation.
48例患者在急性心肌梗死病程早期接受了急诊主动脉 - 冠状动脉搭桥术。症状发作至再灌注的时间间隔为169±80分钟。对19例患者术后进行的201铊心肌扫描定量评估显示,手术再灌注后心肌有显著挽救:残余梗死面积小于匹配的、接受药物治疗的前瞻性对照组(n = 39)的50%(p < 0.05)。术后平衡门控放射性核素血池研究(锝99m)显示,与药物治疗后相比,术后区域和整体射血分数恢复增强(p < 0.05)。术中获取的活检标本的超微结构评估表明,大多数病例(72%)存在心内膜下坏死,但仅6%的病例发现心外膜下坏死。50%的病例术后心电图出现Q波异常。低风险患者(即血流动力学稳定,n = 26)的手术死亡率为0%,高风险患者(即心源性休克包括完全电机械功能障碍,n = 22)的手术死亡率为18%。18个月时的生存率为92%±4%,95%±4%的幸存者无事件发生。结论是,急性心肌梗死早期手术再灌注可显著限制梗死面积,增强功能恢复,对于伴有复苏失败的心源性休克患者可能是一种挽救生命的手术。